MedPath

Effect of fluoxetine on the functional recovery of patients with cerebrovascular accident

Phase 3
Conditions
Cerebral ischemic stroke.
Cerebral infarction due to thrombosis of cerebral arteries
Registration Number
IRCT201112228490N1
Lead Sponsor
Guilan University of Medical Science, Vice chancellor for research and technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

informed consent; unilateral occlusion of middle cerebral artery trunk; resident in Rasht; Admission NIHSS< 20; No history of alcohol abuse; No history of insomnia, epilepsy; No previous history of cerebral hemorrhage and heart of cerebral stroke; No previous history of systemic diseases of other organs, including liver failure and kidney; Absence of cardiac pace maker, severe neuropathy, systemic vascular disease or major affective disorders; Absence of concomitant stroke in an area other than the stroke of the middle cerebral artery. Exclusion criteria: Dissatisfaction of patient during the study; Occurrence of serious adverse drug affects at any time during drug administration; Alcohol abuse during the study period; Occurrence of Post Stroke Depression (PSD) concomitant use of the mono amine oxidase inhibitors or serotonergic drugs such as tricyclic antidepressants and SSRI.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disability. Timepoint: On admission day, on discharge day, 1 and 3 month later. Method of measurement: modified Rankin Scale (mRS).;Performance in basic Activities of Daily Living. Timepoint: On admission day, on discharge day, 1 and 3 month later. Method of measurement: Barthel Index.;Functional recovery. Timepoint: On admission day, on discharge day, 1 and 3 month later. Method of measurement: National Institutes of Health Stroke Scale (NIHSS).;Depression. Timepoint: On admission day, on discharge day, 1 and 3 month later. Method of measurement: Beck Depression Inventory (BDI) questionnaire.
Secondary Outcome Measures
NameTimeMethod
Cerebral blood flow changes of middle cerebral artery. Timepoint: On admission day, on discharge day. Method of measurement: Transcranial Doppler (TCD).
© Copyright 2025. All Rights Reserved by MedPath